• GSK621 and AMPK: From Metabolism to Tumor Immunity

  2026-10-09

  GSK621 is an AMPK agonist that offers a useful pharmacological lens on energy sensing, AML biology, and immunometabolic signaling. This article distinguishes direct compound effects from the lysosomal 25-hydroxycholesterol mechanism reported in Immunity, defining what the evidence supports—and what remains unproven.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-10-09

  Wang et al. used complementary inhibitor, microscopy, and quantitative PCR evidence to examine how genotype III grass carp reovirus enters cultured grass carp kidney cells. Their findings support a dynamin-dependent, acidification-dependent clathrin-mediated entry route, while the reported lack of inhibition by Latrunculin B helps distinguish this process from a simple requirement for actin filament assembly.

• Blue Light, EGFR/ERK/c-Jun, and Skin Barrier Damage

  2026-10-08

  A 2026 Journal of Investigative Dermatology study connects repeated blue-light exposure with persistent skin-barrier impairment, epidermal thickening, pigmentation, and increased transepidermal water loss. By combining human observations, mouse models, imaging, histology, and pathway analysis, the work positions EGFR/ERK/c-Jun signaling as a mechanistic framework while highlighting important limits in exposure specificity and causal interpretation.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-10-08

  Oliveira and colleagues reported that several naturally occurring angiotensin peptides increase the measured binding of SARS-CoV-2 spike protein to host-cell receptors, with the strongest effects associated with selected shorter or N-terminally modified fragments. The study introduces a biochemical link between renin-angiotensin system research and viral receptor biology, while its binding-only design means that effects on infection, disease severity, or treatment remain unproven.

• DAMGO and the Circuit Logic of Opioid Pain

  2026-10-07

  DAMGO is more than a selective µ-opioid receptor agonist: it is a mechanistic probe for separating receptor activation from the distributed circuit processes that shape analgesia, mechanical hypersensitivity, and tolerance. New mouse findings connect MOR-expressing brainstem neurons with hypothalamic dynorphin signaling and spinal KOR-GABA circuitry, creating a stronger framework for opioid receptor signaling research and translational pain science.

• FAISL–FAK Control in Triple-Negative Breast Cancer

  2026-10-07

  The 2024 Advanced Science study identifies FAISL as a focal adhesion kinase-interacting lncRNA that stabilizes FAK by limiting Calpain 2-mediated proteolysis. Its combination of transcriptomic discovery, molecular validation, cancer-cell phenotyping, and targeted siRNA delivery links post-translational FAK control to TNBC progression and metastasis, while leaving important questions about clinical transferability and calcium-dependent regulation open.

• GRE Combination and CREB/MITF Control of Melanogenesis

  2026-10-06

  Huang and colleagues evaluated glabridin, resveratrol, and ellagic acid as a combined GRE composition across melanogenesis, antioxidant, and inflammation-related cellular readouts. The study’s main contribution is a mechanism-oriented link between reduced melanin and tyrosinase activity and suppression of CREB phosphorylation and MITF-associated expression, while its in vitro design limits direct conclusions about clinical efficacy or formal ingredient synergy.

• Silk Fibroin–Ce6 Films for Infected Wound Healing

  2026-10-06

  The reference study combines aligned silk fibroin electrospun fibers with covalently associated Chlorin e6 to create an anisotropic wound film that couples cell-guidance properties with photodynamic antibacterial activity. Its reported findings support a preclinical strategy for controlling Staphylococcus aureus infection while influencing later-stage macrophage behavior, but they do not establish clinical efficacy or anticancer activity.

• Ciprofloxacin in Nanotheranostic Research

  2026-10-05

  This overview examines Ciprofloxacin as a fluoroquinolone antibiotic and research compound, with emphasis on its established bacterial DNA-targeting mechanism and a 2026 preclinical nanotheranostic study in triple-negative breast cancer. It separates reported findings from interpretation and outlines evidence limitations, translational boundaries, and implications for antimicrobial resistance research.

• Mouse Tissue Lysis Kit K1038: Product Overview

  2026-10-05

  The Mouse Tissue Lysis Kit (K1038) is an APExBIO research product described for tissue lysis and direct genotyping workflows. No matched peer-reviewed paper evidence was provided, so performance, reproducibility, and applicability cannot be independently assessed.

• Estrogen–Autophagy Axis in Perimenopausal Aging

  2026-10-04

  A 2026 Life Sciences study integrates NHANES analysis, mouse experiments, and network pharmacology to examine how declining estradiol may affect the heart, aorta, and kidneys during perimenopausal aging. Its findings link estrogen receptor activity and autophagy signaling with reduced multi-organ fibrosis, while the evidence remains limited by observational human data, model dependence, and the interpretive limits of pharmacological inhibitors.

• Angiotensin 1/2 (1-6): A Systems Biology View

  2026-10-03

  Angiotensin 1/2 (1-6) is more than a short renin-angiotensin system fragment. This evidence-focused analysis connects its sequence, vascular and renal relevance, and emerging spike-receptor findings while distinguishing biochemical observation from biological and clinical interpretation.

• a-MSH, amide: From Stimulus to Assay Design

  2026-10-02

  Discover how a-MSH, amide can function as a defined biological stimulus rather than merely a pigmentation reagent. This article connects melanocortin signaling with assay architecture, orthogonal readouts, and careful interpretation of pigmentation and inflammation data.

• Staurosporine in THP-1 Apoptosis Workflows

  2026-10-01

  Build more reproducible apoptosis and kinase-signaling assays by pairing Staurosporine with cryopreservation-aware THP-1 cell handling. This workflow distinguishes compound-driven apoptosis from post-thaw stress while extending the reference study’s assay-ready cell strategy to cancer research and angiogenesis models.

• Pterostilbene and Dermal Fibroblast Senescence

  2026-10-01

  Zhou et al. report that pterostilbene reduces senescence in human dermal fibroblasts by improving mitochondrial quality, including membrane potential, respiration, morphology, and mitophagy-associated clearance. The study links mitochondrial maintenance with collagen preservation across cellular and UVB-exposed mouse models, providing a useful framework for investigating dermal aging mechanisms.

7786 records 1/520 page Next 12345 下5页 Last page